Furthermore, we have shown that APLP2 assists pancreatic cancer cell survival and growth in vitro, and treatment of pancreatic cancer cells with beta-secretase inhibitors decreases both APLP2 cleavage and cell growth [5]. Here, APLP2 is linked to familial pancreatic carcinoma.